These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15788297)

  • 61. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with esophageal cancer.
    Freeman RK; Van Woerkom JM; Vyverberg A; Ascioti AJ
    Ann Thorac Surg; 2011 Oct; 92(4):1239-42; discussion 1243. PubMed ID: 21867990
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prognostic factors in the nonsurgical treatment of esophageal carcinoma with radiotherapy or radiochemotherapy: the importance of pretreatment hemoglobin levels.
    Rades D; Schild SE; Bahrehmand R; Zschenker O; Alberti WA; Rudat VR
    Cancer; 2005 Apr; 103(8):1740-6. PubMed ID: 15742330
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic factors in patients with esophageal carcinoma treated with chemoradiation: single center experience.
    Cincibuch J; Neoral C; Aujeský R; Srámek V; Schneiderka P; Studentová H; Melichar B; Kohoutek M; Stráznická J; Vrba R; Juránová J; Flodr P; Machácek J; Cwiertha K
    Hepatogastroenterology; 2010; 57(102-103):1145-9. PubMed ID: 21410047
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Biologic factors associated with tumor oxygenation are prognostic in patients with stage III esophageal cancer: long-term results.
    Rades D; Bajrovic A; Schild SE; Thorns C; Kilic E
    Anticancer Res; 2014 Aug; 34(8):4351-5. PubMed ID: 25075070
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Statistical review of esophageal cancer in Japan].
    Kato H
    Nihon Rinsho; 1993 Jan; 51 Suppl():670-8. PubMed ID: 8459601
    [No Abstract]   [Full Text] [Related]  

  • 66. [Prognostic value of hormonal and immunological indices in the combined treatment of esophageal cancer].
    Bordiushkov IuN; Rubtsov VR; Maliutina LI; Vagner VP; Cherniavskaia GIa
    Vopr Onkol; 1982; 28(7):13-22. PubMed ID: 7101822
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An evaluation of survival of space maintainers: a six-year follow-up study.
    Tulunoglu O; Ulusu T; Genç Y
    J Contemp Dent Pract; 2005 Feb; 6(1):74-84. PubMed ID: 15719079
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The prognostic value of cholesterol levels in malnourished patients with esophageal carcinoma].
    Faintuch J; Cabraitz R; Martín Nieto AR; Yagi OK; Zilberstein B; Cecconello I; Pinotti HW; Wesdorp RI
    Nutr Hosp; 1993; 8(6):352-7. PubMed ID: 8373878
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Results of treatment of esophageal cancer].
    Peterson BE; Letiagin VP; Vasil'eva ID
    Khirurgiia (Mosk); 1976 Apr; (4):8-12. PubMed ID: 948188
    [No Abstract]   [Full Text] [Related]  

  • 70. [Consecutive radiation and surgical treatment of cancer of the esophagus].
    Pirogov AI; Mamontov AS; Ryndin VD; Davydov MI; Aliev MG
    Sov Med; 1986; (12):113-6. PubMed ID: 3563694
    [No Abstract]   [Full Text] [Related]  

  • 71. [The quality of medical care given to patients with esophageal cancer in St. Petersburg and the Leningrad region].
    Stoliarov VI; Simonov NN; Barchuk AS; Anan'ev NV; Rybin EP; Roman LD; Makeeva TK
    Vopr Onkol; 1997; 43(2):207-9. PubMed ID: 9214125
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Multi-institutional study on an analysis of 2-year survivors with esophageal cancer following radiation therapy].
    Takahashi M; Nishimura Y; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Jan; 48(1):56-64. PubMed ID: 3368296
    [No Abstract]   [Full Text] [Related]  

  • 73. [Figures on esophageal cancer].
    Igaki H; Kato H
    Nihon Rinsho; 2001 Nov; 59 Suppl 7():267-73. PubMed ID: 11808130
    [No Abstract]   [Full Text] [Related]  

  • 74. [Reasons for a late diagnosis in esophageal cancer].
    Khodzhaeva MKh
    Grudn Khir; 1986; (6):69-71. PubMed ID: 3804008
    [No Abstract]   [Full Text] [Related]  

  • 75. Trimodality therapy for esophageal cancer.
    Krasna MJ
    Ann Thorac Surg; 1998 Mar; 65(3):899-900. PubMed ID: 9527259
    [No Abstract]   [Full Text] [Related]  

  • 76. [Evolution of the views on the organization of the treatment of esophageal cancer].
    Chissov VI; Mamontov AS; Gritsman IuIa; Batinov IN; Kukharenko VM
    Sov Med; 1988; (7):66-9. PubMed ID: 2976204
    [No Abstract]   [Full Text] [Related]  

  • 77. [Comment apropos of the article "Esophageal cancer: did combined treatment improve prognosis?" by G. Ganem et al].
    Bosset JF; Gignoux M; Elias D; Triboulet JP; Mantion G; Rougier P
    Bull Cancer; 1993 Mar; 80(3):261-4. PubMed ID: 8173179
    [No Abstract]   [Full Text] [Related]  

  • 78. Treatments for esophageal cancer.
    Haller DG
    N Engl J Med; 1992 Jun; 326(24):1629-31. PubMed ID: 1584267
    [No Abstract]   [Full Text] [Related]  

  • 79. Possible predictive markers of immunotherapy in esophageal cancer: retrospective analysis of a randomized study. The Cooperative Study Group for Esophageal Cancer in Japan.
    Ogoshi K; Satou H; Isono K; Mitomi T; Endoh M; Sugita M
    Cancer Invest; 1995; 13(4):363-9. PubMed ID: 7627722
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Carcinoma of the esophagus: is biology screaming in my deaf ears?
    Ajani JA
    J Clin Oncol; 2005 Jul; 23(19):4256-8. PubMed ID: 15781878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.